A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
Public ClinicalTrials.gov record NCT06885424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2Bio) Gene Therapy (GT) Products
Study identification
- NCT ID
- NCT06885424
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- A2 Biotherapeutics Inc.
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
- Colorectal Carcinoma
- Colorectal Carcinoma (CRC)
- Head and Neck (HNSCC)
- Head and Neck Cancer
- Mesothelioma
- NSCLC
- Non Small Cell Lung Cancer
- Ovarian Cancer
- Ovarian Carcinoma
- Pancreatic Cancer
- Renal Cell Carcinoma (Kidney Cancer)
- Small Cell Lung Cancer ( SCLC )
- Solid Tumor Cancer
- Solid Tumor, Unspecified, Adult
- Triple Negative Breast Cancer (TNBC)
Interventions
- No additional intervention administered in this long term follow-up study Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2025
- Primary completion
- Mar 30, 2030
- Completion
- Mar 30, 2040
- Last update posted
- May 19, 2026
2025 – 2040
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Health | Gilbert | Arizona | 85234 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06885424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06885424 live on ClinicalTrials.gov.